4.7 Article

High body mass index has a deleterious effect on semen parameters except morphology: results from a large cohort study

Journal

FERTILITY AND STERILITY
Volume 102, Issue 5, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2014.07.1212

Keywords

BMI; semen volume; concentration; motility; morphology; obesity

Funding

  1. Laboratoire Genevrier
  2. Laboratoire Ferring
  3. Lilly

Ask authors/readers for more resources

Objective: To evaluate the influence of body mass index (BMI) on semen characteristics. Design: Cohort study. Setting: Single private andrology laboratory. Patient(s): All patients (n = 10,665) consulting for a semen analysis from October 9, 2010, to October 8, 2011. When analyses were repeated on the same patient, only the first was included. Intervention(s): Recording of self-reported weight and height and of semen analysis. Main Outcome Measure(s): All parameters of standard semen analysis: pH, volume, sperm concentration per mL, total sperm count per ejaculate, motility (%) within 1 hour after ejaculation (overall and progressive), viability (%), and normal sperm morphology (%). Parametric and nonparametric statistical methods were applied, and results are given either with mean +/- SD, or 10th, 50th, and 90th percentiles. Result(s): Semen volume decreased from 3.3 +/- 1.6 to 2.7 +/- 1.6 mL when BMI increased from normal (20-25 kg/m(2)) to extreme obesity (>40 kg/m(2)). The same was true for semen concentration (56.4 +/- 54.9 to 39.4 +/- 51.0 million/mL), total sperm count (171 +/- 170 to 92 +/- 95 million), and progressive motility (36.9 +/- 16.8% to 34.7 +/- 17.1%). The percentage of cases with azoospermia and cryptozoospermia increased from 1.9% to 9.1% and from 4.7% to 15.2%, respectively. The other semen characteristics were not affected. Multivariate models including age and abstinence duration confirmed these results. Conclusion(s): In this study, on a large patient sample size, increased BMI was associated with decreased semen quality, affecting volume, concentration, and motility. The percentage of normal forms was not decreased. (C) 2014 by American Society for Reproductive Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Obstetrics & Gynecology

Assisted reproductive technologies in Africa: first results from the African Network and Registry for Assisted Reproductive Technology, 2013

Silke Dyer, Paversan Archary, Jacques de Mouzon, Moise Fiadjoe, Oladapo Ashiru

REPRODUCTIVE BIOMEDICINE ONLINE (2019)

Editorial Material Obstetrics & Gynecology

ART utilization: an indicator of access to infertility care COMMENT

Silke Dyer, Georgina M. Chambers, G. David Adamson, Manish Banker, Jacques De Mouzon, Osamu Ishihara, Markus Kupka, Ragaa Mansour, Fernando Zegers-Hochschild

REPRODUCTIVE BIOMEDICINE ONLINE (2020)

Review Obstetrics & Gynecology

The experience of in vitro fertilization data collection in Turkey

Mete Isikoglu, Jacques de Mouzon

Summary: The contribution of Turkey to the European IVF data registry was significant from 2008 to 2012, with the country ranking among the top six contributors in Europe. However, this contribution ceased after 2012, highlighting the importance of regular and systematic data submission for achieving a complete dataset. Continuing to include Turkish IVF data in the European registry would greatly enhance the overall accuracy and completeness of the ESHRE EIM database.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study

Sylvie Epelboin, Julie Labrosse, Jacques De Mouzon, Patricia Fauque, Marie-Jose Gervoise-Boyer, Rachel Levy, Nathalie Sermondade, Laetitia Hesters, Marianne Bergere, Claire Devienne, Philippe Jonveaux, Jade Ghosn, Fabienne Pessione

Summary: During the first wave of the COVID-19 pandemic, pregnant women with COVID-19 diagnosis showed higher frequencies of maternal morbidities and adverse obstetrical outcomes compared to pregnant women without COVID-19 diagnosis, highlighting the importance of awareness and care for this population.

PLOS MEDICINE (2021)

No Data Available